1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia

被引：67

作者：

Anandan, Sampath-Kumar ^{[1
]}

Webb, Heather Kay ^{[1
]}

Chen, Dawn ^{[1
]}

Wang, Yi-Xin ^{[1
]}

Aavula, Basker R. ^{[1
]}

Cases, Sylvaine ^{[1
]}

Cheng, Ying ^{[1
]}

Do, Zung N. ^{[1
]}

Mehra, Upasana ^{[1
]}

Vinh Tran ^{[1
]}

Vincelette, Jon ^{[1
]}

Waszczuk, Joanna ^{[1
]}

White, Kathy ^{[1
]}

Wong, Kenneth R. ^{[1
]}

Zhang, Le-Ning ^{[1
]}

Jones, Paul D. ^{[2
,3
]}

Hammock, Bruce D. ^{[2
,3
]}

Patel, Dinesh V. ^{[1
]}

Whitcomb, Randall ^{[1
]}

MacIntyre, D. Euan ^{[1
]}

Sabry, James ^{[1
]}

Gless, Richard ^{[1
]}

机构：

[1] Arete Therapeut Inc, San Francisco, CA 94080 USA

[2] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA

[3] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 03期

关键词：

sEH inhibitor; AR9281; Efficacy; DIO model; AngII hypertension model; Diabetes; EPOXYEICOSATRIENOIC ACIDS; INSULIN-RESISTANCE; 12-(3-ADAMANTAN-1-YL-UREIDO)DODECANOIC ACID; VASCULAR INFLAMMATION; BLOOD-PRESSURE; HIGHLY POTENT; PHARMACOKINETICS; METABOLISM; DISCOVERY; ATHEROSCLEROSIS;

D O I：

10.1016/j.bmcl.2010.12.042

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea 14a (AR9281), a potent and selective soluble epoxide hydrolase inhibitor, was recently tested in a phase 2a clinical setting for its effectiveness in reducing blood pressure and improving insulin resistance in pre-diabetic patients. In a mouse model of diet induced obesity, AR9281 attenuated the enhanced glucose excursion following an intraperitoneal glucose tolerance test. AR9281 also attenuated the increase in blood pressure in angiotensin-II-induced hypertension in rats. These effects were dose-dependent and well correlated with inhibition of the sEH activity in whole blood, consistent with a role of sEH in the observed pharmacology in rodents. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：983 / 988

页数：6

共 15 条

[1] In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
Wan, Debin
Yang, Jun
McReynolds, Cindy B.
Barnych, Bogdan
Wagner, Karen M.
Morisseau, Christophe
Hwang, Sung Hee
Sun, Jia
Blocher, Rene
Hammock, Bruce D.
FRONTIERS IN PHARMACOLOGY, 2019, 10
[2] A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis
Jonnalagadda, Deepa
Wan, Debin
Chun, Jerold
Hammock, Bruce D.
Kihara, Yasuyuki
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
[3] Protective Effects of the Soluble Epoxide Hydrolase Inhibitor 1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea in a Rat Model of Permanent Middle Cerebral Artery Occlusion
Zhang, Linlei
Xu, Shasha
Wu, Xiaoxiao
Muse, Farah Mohamed
Chen, Jiaou
Cao, Yungang
Yan, Jueyue
Cheng, Zicheng
Yi, Xingyang
Han, Zhao
FRONTIERS IN PHARMACOLOGY, 2020, 11
[4] Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice
Yong Zhou
Guo-Ying Sun
Tian Liu
Jia-Xi Duan
Hui-Fang Zhou
Kin Sing Lee
Bruce D. Hammock
Xiang Fang
Jian-Xin Jiang
Cha-Xiang Guan
Cell and Tissue Research, 2016, 363 : 399 - 409
[5] Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice
Zhou, Yong
Sun, Guo-Ying
Liu, Tian
Duan, Jia-Xi
Zhou, Hui-Fang
Lee, Kin Sing
Hammock, Bruce D.
Fang, Xiang
Jiang, Jian-Xin
Guan, Cha-Xiang
CELL AND TISSUE RESEARCH, 2016, 363 (02) : 399 - 409
[6] 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells
Liang, Zhibin
Zhang, Bei
Xu, Meng
Morisseau, Christophe
Hwang, Sung Hee
Hanunock, Bruce D.
Li, Qing X.
ACS CHEMICAL NEUROSCIENCE, 2019, 10 (09): : 4018 - 4030
[7] Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke
Shaik, Jafar Sadik B.
Ahmad, Muzamil
Li, Wenjin
Rose, Marie E.
Foley, Lesley M.
Hitchens, T. Kevin
Graham, Steven H.
Hwang, Sung Hee
Hammock, Bruce D.
Poloyac, Samuel M.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2013, 305 (11): : H1605 - H1613
[8] Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern
Ostermann, Annika I.
Herbers, Jan
Willenberg, Ina
Chen, Rongjun
Hwang, Sung Hee
Greite, Robert
Morisseau, Christophe
Gueler, Faikah
Hammock, Bruce D.
Schebb, Nils Helge
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2015, 121 : 131 - 137
[9] 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats
Bukhari, I. A.
Mohamed, O. Y.
Mahmood, A.
Alfadda, A. A.
Almotrefi, A. A.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (10) : 3835 - 3847
[10] Design, synthesis and biological evaluation of 4-(1-(4(sulphanilamide)phenyl)-3-(methyl)-1H-pyrazol-5-yl)dine urea and N-acyl derivatives as a soluble epoxide hydrolase inhibitors
Nimbarte, Vijaykumar D.
Murtuza, Hadianawala
Phaniraj, Sahishna
Shrivastava, Shweta
Naidu, V. G. M.
Kumar, N. Satheesh
Atcha, Krishnam Raju
MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (05) : 2178 - 2197

← 1 2 →